196 related articles for article (PubMed ID: 23395204)
1. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia.
McPhee JT; Nguyen LL; Ho KJ; Ozaki CK; Conte MS; Belkin M
J Vasc Surg; 2013 Jun; 57(6):1481-8. PubMed ID: 23395204
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of 30-day unplanned readmission after lower extremity bypass.
McPhee JT; Barshes NR; Ho KJ; Madenci A; Ozaki CK; Nguyen LL; Belkin M
J Vasc Surg; 2013 Apr; 57(4):955-62. PubMed ID: 23332242
[TBL] [Abstract][Full Text] [Related]
3. The Comprehensive Risk Assessment for Bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia.
Meltzer AJ; Graham A; Connolly PH; Meltzer EC; Karwowski JK; Bush HL; Schneider DB
J Vasc Surg; 2013 May; 57(5):1186-95. PubMed ID: 23375435
[TBL] [Abstract][Full Text] [Related]
4. Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123-130.
Kreatsoulas C; Anand SS
Vasc Med; 2009 Nov; 14(4):397-9. PubMed ID: 19808727
[TBL] [Abstract][Full Text] [Related]
5. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
Schanzer A; Hevelone N; Owens CD; Beckman JA; Belkin M; Conte MS
J Vasc Surg; 2008 Apr; 47(4):774-781. PubMed ID: 18381138
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term readmission rates after infrainguinal bypass in a safety net hospital are higher than expected.
Krafcik BM; Komshian S; Lu K; Roberts L; Farber A; Kalish JA; Rybin D; Siracuse JJ
J Vasc Surg; 2017 Dec; 66(6):1786-1791. PubMed ID: 28965800
[TBL] [Abstract][Full Text] [Related]
7. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia.
Arvela E; Söderström M; Albäck A; Aho PS; Venermo M; Lepäntalo M
J Vasc Surg; 2010 Sep; 52(3):616-23. PubMed ID: 20615645
[TBL] [Abstract][Full Text] [Related]
8. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia.
Chung J; Bartelson BB; Hiatt WR; Peyton BD; McLafferty RB; Hopley CW; Salter KD; Nehler MR
J Vasc Surg; 2006 Jun; 43(6):1183-90. PubMed ID: 16765235
[TBL] [Abstract][Full Text] [Related]
9. Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events.
Nguyen LL; Lipsitz SR; Bandyk DF; Clowes AW; Moneta GL; Belkin M; Conte MS
J Vasc Surg; 2006 Nov; 44(5):971-5; discussion 975-6. PubMed ID: 17098527
[TBL] [Abstract][Full Text] [Related]
10. Reoperative lower extremity revascularization with cadaver vein for limb salvage.
Bannazadeh M; Sarac TP; Bena J; Srivastava S; Ouriel K; Clair D
Ann Vasc Surg; 2009; 23(1):24-31. PubMed ID: 18657383
[TBL] [Abstract][Full Text] [Related]
11. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.
Conte MS; Bandyk DF; Clowes AW; Moneta GL; Seely L; Lorenz TJ; Namini H; Hamdan AD; Roddy SP; Belkin M; Berceli SA; DeMasi RJ; Samson RH; Berman SS;
J Vasc Surg; 2006 Apr; 43(4):742-751; discussion 751. PubMed ID: 16616230
[TBL] [Abstract][Full Text] [Related]
12. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage.
Goshima KR; Mills JL; Hughes JD
J Vasc Surg; 2004 Feb; 39(2):330-5. PubMed ID: 14743132
[TBL] [Abstract][Full Text] [Related]
13. The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*.
Horkan CM; Purtle SW; Mendu ML; Moromizato T; Gibbons FK; Christopher KB
Crit Care Med; 2015 Feb; 43(2):354-64. PubMed ID: 25474534
[TBL] [Abstract][Full Text] [Related]
14. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions.
Taylor SM; Kalbaugh CA; Blackhurst DW; Cass AL; Trent EA; Langan EM; Youkey JR
J Vasc Surg; 2006 Oct; 44(4):747-55; discussion 755-6. PubMed ID: 16926083
[TBL] [Abstract][Full Text] [Related]
15. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia.
Nguyen LL; Brahmanandam S; Bandyk DF; Belkin M; Clowes AW; Moneta GL; Conte MS
J Vasc Surg; 2007 Dec; 46(6):1191-1197. PubMed ID: 18154995
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.
Bodewes TC; Soden PA; Ultee KH; Zettervall SL; Pothof AB; Deery SE; Moll FL; Schermerhorn ML
J Vasc Surg; 2017 Feb; 65(2):484-494.e3. PubMed ID: 28126175
[TBL] [Abstract][Full Text] [Related]
17. Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass.
McPhee JT; Barshes NR; Ozaki CK; Nguyen LL; Belkin M
J Vasc Surg; 2012 Apr; 55(4):1008-14. PubMed ID: 22365176
[TBL] [Abstract][Full Text] [Related]
18. Perioperative outcomes and amputation-free survival after lower extremity bypass surgery in California hospitals, 1996-1999, with follow-up through 2004.
Feinglass J; Sohn MW; Rodriguez H; Martin GJ; Pearce WH
J Vasc Surg; 2009 Oct; 50(4):776-783.e1. PubMed ID: 19595538
[TBL] [Abstract][Full Text] [Related]
19. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.
Schanzer A; Goodney PP; Li Y; Eslami M; Cronenwett J; Messina L; Conte MS;
J Vasc Surg; 2009 Oct; 50(4):769-75; discussion 775. PubMed ID: 19628361
[TBL] [Abstract][Full Text] [Related]
20. Readmission rates after lower extremity bypass vary significantly by surgical indication.
Jones CE; Richman JS; Chu DI; Gullick AA; Pearce BJ; Morris MS
J Vasc Surg; 2016 Aug; 64(2):458-464. PubMed ID: 27139788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
